Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 5105 - 5112 of 12004 results

Physician Affiliation Price Fixing Case Settled for $2.5 Million

May 31, 2019| Alert| Viewpoint

Federal Circuit Affirms that the ITC Cannot Investigate an FDCA Violation without the FDA’s say-so

May 30, 2019| Blog| Viewpoint

Supreme Court Adopts a “Rejection-as-Breach” Rule to Allow Licensee to Continue to Use Trademark Following Debtor’s Rejection of License

May 29, 2019| Blog| Viewpoint

Claim Construction of “Customary and Ordinary” Meaning Does Not Justify Amendment of Noninfringement and Invalidity Contentions

May 29, 2019| Blog| Viewpoint

Claimants Need Not Record Complaints to Enforce Lien Dissolution Bonds Under

May 28, 2019| Blog| Viewpoint

CMS Finalizes Medicare Advantage and Part D Drug Pricing Rule

May 28, 2019| Blog| Viewpoint

Maryland’s Prescription Drug Affordability Board Bill Set to Take Effect

May 28, 2019| Blog| Viewpoint

Performing a Service without Selling the Process Still Triggers the On-Sale Bar

May 24, 2019| Blog| Viewpoint

News & Press Releases

Mintz Advises Syntis Bio on $33 Million Series A Financing

July 02, 2025

Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.

Mintz Obtains Trademark TRO Against OpenAI on Behalf of IYO, Inc.

June 30, 2025

Mintz secured a rare trademark temporary restraining order (TRO) on behalf of IYO, Inc. against OpenAI, Sam Altman, Sir Jony Ive, and IO Products, Inc. The order temporarily bars the defendants from using the trademark associated with their new product launch.

Mintz Advises Brij in $8M Oversubscribed Funding Round

June 26, 2025

Mintz advised Brij—a software platform enhancing the consumer experience by bridging online and offline commerce—on the closing of its $8 million Series Seed round. The funding will help Brij advance its mission to close the trillion-dollar disconnect between brands and their retail customers and power the next generation of offline-to-online customer relationships.

View all News and Press Releases